Couples Motivational Interviewing to Reduce Drug Use and HIV Risk in Vulnerable Male Couples
- Conditions
- Substance UseHIV Infections
- Interventions
- Behavioral: Couples Health Project
- Registration Number
- NCT06307977
- Lead Sponsor
- Hunter College of City University of New York
- Brief Summary
This study utilizes a randomized controlled trial design to evaluate the efficacy of couples motivational interviewing (MI) to reduce the frequency and severity of illicit drug use and frequency of HIV transmission risk behavior (TRB). Participants are randomized to one of two conditions: couples MI or standard couples HIV testing and counseling (CHTC).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Male
- Target Recruitment
- 360
- Have a main partner who is another cisgender male and have been in a relationship for 3 month or longer
- Index participant must be between 18 and 34; Main partner can be any age 18 and older
- One participant must be HIV negative (as confirmed by rapid test)
- One participant must have used at least 1 drug in the past 30 days (cocaine/crack, opiates, misuse of prescription medication, stimulants, psychedelics, ecstasy, ketamine, GHB, amyl nitrite)
- Index participant must have engaged in TRB in the past 30 days- Defined as CAS with a casual partner, or a serodiscordant or non-monogamous main partner
- Live in the United States
- Speak and read English
Exclusion Criteria
- Any signs of serious mental illness or cognitive deficit
- Current suicidal/homicidal ideations
- History of IPV with their main partner and safety concerns in the current relationship.
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- FACTORIAL
- Arm && Interventions
Group Intervention Description Behavioral: Couples Health Project Couples Health Project A three-session intervention for couples addressing couples communication skills, substance use, sexual agreements. The intervention also includes couples HIV testing and counseling in the final session.
- Primary Outcome Measures
Name Time Method Urine assay for drug use 9 Months Positive urine screen for drug use assessed bi-annually
Drug use Frequency 9 Months Number of reported days of illicit drug use (amphetamines, cocaine/crack, GHB, ketamine or ecstasy) reported on quarterly timeline follow-back assessments
CAS with casual partners 9 Months Number of total anal sex acts (insertive and receptive) with casual partners reported on quarterly timeline follow-back assessments in the absence of adequate PrEP coverage
- Secondary Outcome Measures
Name Time Method Binge Drinking 9 Months Number of days on which 5 or more drinks containing alcohol were reported on the quarterly timeline follow-back interview
PrEP Uptake 9 months self-reported receipt of a PrEP-prescription
Bacterial sexually transmitted infections 9 Months Any chlamydia or gonorrhea diagnosis
Trial Locations
- Locations (3)
University of Virginia
🇺🇸Charlottesville, Virginia, United States
Wayne State University
🇺🇸Detroit, Michigan, United States
Hunter College
🇺🇸New York, New York, United States